Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial
Primary result · Percentage of days lost due to cardiovascular hospitalization or deathResult — go to the resultHazard ratio 0.66 95% CI 0.48–0.90Authors' conclusion
These results support the use of RPM in HF patients with diabetes.
Study context
- Population
- Heart failure (HF) patients with diabetes in NYHA class II/III with an HF-related hospital admission within the previous 12 months, irrespective of LVEF; Germany, August 2013–May 2018HF patients with diabetes
- Participants
- 707 patients
- Comparison
- Usual care with added remote patient management vs usual care
- Primary endpoint
- Days lost due to unplanned cardiovascular hospitalization or due to death of any cause
- Follow-up
- 1 year
Methodological detailsrandomized, controlled, unmasked (concealed randomization), multicentre
- Randomized
- Controlled
- Unmasked (concealed randomization)
- Multicentre
Primary result
As reported in the abstract
Percentage of days lost due to cardiovascular hospitalization or death
Hazard ratio
0.66
95% CI 0.48–0.90
RPMvs Usual care
HR 0.66 (95% CI 0.48–0.90)
Further findings
| Outcome | HR (95% CI) | |
|---|---|---|
| All-cause mortality | 0.52 (0.32–0.85) | |
| 0.20.5125Hazard ratio (log scale) |
| Outcome | Mean difference (95% CI) |
|---|---|
| Quality of life: change in MLHFQ global scoreImprovement in quality of life with RPM | - 3.4 (- 6.2 to - 0.6) |
Original publication
Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial. Cardiovasc Diabetol. Published 12 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →